In our study, comparing the COVID-19 positive G6PD deficient group with COVID-19 negative G6PD deficient group showed that COVID-19 infection increased significantly the total WBC, lymphocytes count, and ANC but did not increase bilirubin level or decreased Hb level or hematocrit (no hemolysis). This evidence concerns the gene GSTM1 and COVID-19.